NAVBQ (Navidea Biopharmaceuticals) E10: $-0.97 (As of Sep. 2023)


NAVBQ Navidea Biopharmaceuticals Inc NAVBQ
16 GF Score
Price $0.00
View Full Analysis

What is Navidea Biopharmaceuticals E10?

Navidea Biopharmaceuticals NAVBQ 16 E10 is $-0.97 as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Navidea Biopharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2023 was $-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.97 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Navidea Biopharmaceuticals's current stock price is $0.0001. Navidea Biopharmaceuticals's E10 for the quarter that ended in Sep. 2023 was $-0.97. Navidea Biopharmaceuticals's Shiller PE Ratio of today is .


Navidea Biopharmaceuticals  (OTCPK:NAVBQ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Navidea Biopharmaceuticals E10 Related Terms


Navidea Biopharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals E10 Chart

Navidea Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.62 -3.53 -1.86 -2.13 -1.56

Navidea Biopharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.74 -1.56 -1.43 -1.20 -0.97

NAVBQ vs PKBO, RSPI, ATRX: E10 Comparison

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navidea Biopharmaceuticals Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Shiller PE Ratio falls into.


NAVBQ
16GF Score
Navidea Biopharmaceuticals Inc NAVBQ
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Navidea Biopharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Navidea Biopharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.02/307.7890*307.7890
=-0.020

Current CPI (Sep. 2023) = 307.7890.

Navidea Biopharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201312 -2.000 233.049 -2.641
201403 -1.600 236.293 -2.084
201406 -1.400 238.343 -1.808
201409 -1.000 238.031 -1.293
201412 -1.000 234.812 -1.311
201503 -1.000 236.119 -1.304
201506 -1.200 238.638 -1.548
201509 -1.000 237.945 -1.294
201512 -0.400 236.525 -0.521
201603 -0.400 238.132 -0.517
201606 -0.800 241.018 -1.022
201609 0.000 241.428 0.000
201612 -0.400 241.432 -0.510
201703 10.400 243.801 13.130
201706 -0.600 244.955 -0.754
201709 -0.200 246.819 -0.249
201712 -0.600 246.524 -0.749
201803 -0.830 249.554 -1.024
201806 -0.290 251.989 -0.354
201809 -0.460 252.439 -0.561
201812 -0.400 251.233 -0.490
201903 -0.240 254.202 -0.291
201906 -0.240 256.143 -0.288
201909 -0.170 256.759 -0.204
201912 -0.150 256.974 -0.180
202003 -0.130 258.115 -0.155
202006 -0.110 257.797 -0.131
202009 -0.130 260.280 -0.154
202012 -0.110 260.474 -0.130
202103 -0.110 264.877 -0.128
202106 -0.090 271.696 -0.102
202109 -0.080 274.310 -0.090
202112 -0.120 278.802 -0.132
202203 -0.100 287.504 -0.107
202206 -0.100 296.311 -0.104
202209 -0.250 296.808 -0.259
202212 -0.110 296.797 -0.114
202303 -0.050 301.836 -0.051
202306 0.120 305.109 0.121
202309 -0.020 307.789 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.97 mean?
Navidea Biopharmaceuticals (NAVBQ) has a E10 of $-0.97 as of Sep. 2023. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Navidea Biopharmaceuticals and its competitors.
Is Navidea Biopharmaceuticals' E10 too high?
Navidea Biopharmaceuticals' current E10 is $-0.97. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Navidea Biopharmaceuticals' E10 compare to PKBO and RSPI?
Navidea Biopharmaceuticals' E10 of $-0.97 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Navidea Biopharmaceuticals and its competitors. Navidea Biopharmaceuticals's current E10 is $-0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navidea Biopharmaceuticals stock overvalued right now?
Navidea Biopharmaceuticals (NAVBQ) has a current E10 of $-0.97. The current E10 is $-0.97. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current E10 is $-0.97 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
16GF Score

Get the complete analysis for NAVBQ

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price